ArticleTherapeutic advances in urology

The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide.

Juan José Serrano Domingo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.